TITLE
Prognostic gene signature for AML

ORGANISM
Homo sapiens

SUMMARY
Acute myeloid leukemia (AML) is a heterogeneous disease in respect of molecular aberrations and prognosis. We used gene expression profiling of 562 patients treated in the German AMLCG 1999 trial to develop a gene signature that predicts survival in AML.

DESIGN
Analysis of 562 samples (140 HGU-133plus2; 422 HGU-133A; 422 HGU-133B) from adult patients with acute myeloid leukemia (AML).

PLATFORM
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array GPL97 [HG-U133B] Affymetrix Human Genome U133B Array GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

CITATIONS
23382473 , 24923295 , 24608088 , 27280396

